Pancreatic Cancer Research

ResearcherJilin UniversityActive in the last 2 years

Ruobing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6176-2023; OpenAlex author ID A5100778733. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 4 papers

Papers 8

  1. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation. Co-author DOI 10.1016/j.freeradbiomed.2024.05.031↗
  2. The NF-κB/NUAK2 signaling axis regulates pancreatic cancer progression by targeting SMAD2/3. Co-author DOI 10.1016/j.isci.2024.109406↗
  3. FBXO32 Stimulates Protein Synthesis to Drive Pancreatic Cancer Progression and Metastasis. First author DOI 10.1158/0008-5472.can-23-3638↗
  4. Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer. Co-author DOI 10.1186/s12943-024-02050-7↗
  5. Novel strategies optimize immunotherapy by improving the cytotoxic function of T cells for pancreatic cancer treatment. Co-author DOI 10.1016/j.canlet.2023.216423↗
  6. Epidemiology of pancreatic cancer: New version, new vision. Co-author DOI 10.21147/j.issn.1000-9604.2023.05.03↗
  7. Combining Gemcitabine-Loaded Macrophage-like Nanoparticles and Erlotinib for Pancreatic Cancer Therapy. First author DOI 10.1021/acs.molpharmaceut.0c01225↗
  8. High Trophinin‑Associated Protein Expression and Its Role in Prognosis of Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-32296/v1↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinxin Tao · 6 shared papers, 2023–2024 · strength 1.12
  2. Taiping Zhang · 6 shared papers, 2023–2024 · strength 1.12
  3. Wenhao Luo · 5 shared papers, 2023–2024 · strength 0.97
  4. Yueze Liu · 5 shared papers, 2023–2024 · strength 0.93
  5. Jiangdong Qiu · 4 shared papers, 2023–2024 · strength 0.73
  6. Dan Su · 3 shared papers, 2023–2024 · strength 0.54
  7. Jiangdong Qiu · 2 shared papers, 2024 · strength 0.39
  8. Jun Wang · 2 shared papers, 2023 · strength 0.33
  9. Tao Liu · 1 shared paper, 2024 · strength 0.20
  10. Gang Yang · 1 shared paper, 2024 · strength 0.20
  11. Dan Su · 1 shared paper, 2024 · strength 0.20
  12. Hua Huang · 1 shared paper, 2024 · strength 0.20
  13. Zhe Cao · 1 shared paper, 2024 · strength 0.20
  14. Yifan Fu · 1 shared paper, 2024 · strength 0.20
  15. Yuanyang Wang · 1 shared paper, 2024 · strength 0.20
  16. Guangyu Chen · 1 shared paper, 2024 · strength 0.20
  17. Dan Su · 1 shared paper, 2024 · strength 0.20
  18. Yupei Zhao · 1 shared paper, 2024 · strength 0.20
  19. Haowei Ma · 1 shared paper, 2023 · strength 0.17
  20. Wenhao Luo · 1 shared paper, 2023 · strength 0.16
  21. Lei You · 1 shared paper, 2023 · strength 0.16
  22. Hongqiao Cai · 1 shared paper, 2021 · strength 0.15
  23. Xingren Guo · 1 shared paper, 2021 · strength 0.15
  24. Yahui Liu · 1 shared paper, 2021 · strength 0.15
  25. Yahui Liu · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.